Subscribe Now to unlock all the Features! Learn More
Get Company Summary for  
Print Print Add Summary to Dashboard Add Filings Alert
INHIBIKASE THERAPEUTICS, INC. (IKT) Summary
 Latest Filings More
View Form Filer Received Period
Download / Print
Actions
View Filing in HTMLView Filing in RTFView Filing in PDFView Filing in ExcelView Filing in Original FormatView Filing in XBRLView Filing in Redline  10-Q   INHIBIKASE THERAPEUTICS, INC.  08/14/24 06/30/24   File this document to a folder.
View Filing in HTMLView Filing in RTFView Filing in PDFView Filing in ExcelView Filing in Original FormatView Filing in XBRL  8-K   INHIBIKASE THERAPEUTICS, INC.  08/06/24 08/05/24   File this document to a folder.
View Filing in HTMLView Filing in RTFView Filing in PDFView Filing in ExcelView Filing in Original Format  4   GRINT PAUL C  07/18/24 07/16/24   File this document to a folder.
View Filing in HTMLView Filing in RTFView Filing in PDFView Filing in ExcelView Filing in Original Format  4   DION GISELE  07/18/24 07/16/24   File this document to a folder.
View Filing in HTMLView Filing in RTFView Filing in PDFView Filing in ExcelView Filing in Original Format  4   BERMAN DENNIS N  07/18/24 07/16/24   File this document to a folder.
View Filing in HTMLView Filing in RTFView Filing in PDFView Filing in ExcelView Filing in Original Format  4   FREEMAN ROY LESTER  07/18/24 07/16/24   File this document to a folder.
View Filing in HTMLView Filing in RTFView Filing in PDFView Filing in ExcelView Filing in Original Format  424B3   INHIBIKASE THERAPEUTICS, INC.  06/27/24   File this document to a folder.
View Filing in HTMLView Filing in RTFView Filing in PDFView Filing in Original Format  EFFECT   INHIBIKASE THERAPEUTICS, INC.  06/27/24   File this document to a folder.
View Filing in HTMLView Filing in RTFView Filing in PDFView Filing in Original Format  DEFA14A   INHIBIKASE THERAPEUTICS, INC.  06/21/24   File this document to a folder.
View Filing in HTMLView Filing in RTFView Filing in PDFView Filing in ExcelView Filing in Original Format  DEF 14A   INHIBIKASE THERAPEUTICS, INC.  06/20/24 08/05/24   File this document to a folder.
 
 Institutional Holders
Total Number of Holders 16
% of Shares Outstanding 11.21%
Total Shares Held 836,496
Total Value of Holdings $978,700.32
Net Activity 630,938
 Latest Company News   Date
(Quotes provided by Thomson Reuters are delayed by 15 minutes or more.)